The University of Chicago Header Logo

Connection

Godfrey Getz to Atherosclerosis

Back to Details
This is a "connection" page, showing publications Godfrey Getz has written about Atherosclerosis.
Godfrey Getz
Connection Strength
13.664
Atherosclerosis
  1. Insights from Murine Studies on the Site Specificity of Atherosclerosis. Int J Mol Sci. 2024 Jun 09; 25(12).
    View in: PubMed
    Score: 0.745
  2. ILRUNing to Atherosclerosis. Arterioscler Thromb Vasc Biol. 2022 09; 42(9):1152-1153.
    View in: PubMed
    Score: 0.656
  3. Pig and Mouse Models of Hyperlipidemia and Atherosclerosis. Methods Mol Biol. 2022; 2419:379-411.
    View in: PubMed
    Score: 0.630
  4. Atherosclerosis: cell biology and lipoproteins. Curr Opin Lipidol. 2020 10; 31(5):286-290.
    View in: PubMed
    Score: 0.577
  5. Atherosclerosis: cell biology and lipoproteins. Curr Opin Lipidol. 2020 02; 31(1):35-37.
    View in: PubMed
    Score: 0.551
  6. Invariant Natural Killer T-Cells and Total CD1d Restricted Cells Differentially Influence Lipid Metabolism and Atherosclerosis in Low Density Receptor Deficient Mice. Int J Mol Sci. 2019 Sep 14; 20(18).
    View in: PubMed
    Score: 0.537
  7. Diet, Microbes, and Murine Atherosclerosis. Arterioscler Thromb Vasc Biol. 2018 10; 38(10):2269-2271.
    View in: PubMed
    Score: 0.503
  8. Genetic control of apoprotein A-I and atheroprotection: some insights from inbred strains of mice. Curr Opin Lipidol. 2017 Oct; 28(5):403-407.
    View in: PubMed
    Score: 0.469
  9. Natural killer T cells in atherosclerosis. Nat Rev Cardiol. 2017 05; 14(5):304-314.
    View in: PubMed
    Score: 0.447
  10. Serum amyloid A and atherosclerosis. Curr Opin Lipidol. 2016 10; 27(5):531-5.
    View in: PubMed
    Score: 0.437
  11. Do the Apoe-/- and Ldlr-/- Mice Yield the Same Insight on Atherogenesis? Arterioscler Thromb Vasc Biol. 2016 09; 36(9):1734-41.
    View in: PubMed
    Score: 0.430
  12. ApoE knockout and knockin mice: the history of their contribution to the understanding of atherogenesis. J Lipid Res. 2016 05; 57(5):758-66.
    View in: PubMed
    Score: 0.422
  13. Atherogenic lipids and macrophage subsets. Curr Opin Lipidol. 2015 Oct; 26(5):357-61.
    View in: PubMed
    Score: 0.408
  14. Use of Mouse Models in Atherosclerosis Research. Methods Mol Biol. 2015; 1339:1-16.
    View in: PubMed
    Score: 0.388
  15. Myeloperoxidase-mediated dysfunctional high-density lipoprotein. Arterioscler Thromb Vasc Biol. 2014 Apr; 34(4):695-6.
    View in: PubMed
    Score: 0.368
  16. Animal models of atherosclerosis. Arterioscler Thromb Vasc Biol. 2012 May; 32(5):1104-15.
    View in: PubMed
    Score: 0.318
  17. Atherosclerosis: beyond cholesterol. Curr Opin Lipidol. 2011 Dec; 22(6):507-8.
    View in: PubMed
    Score: 0.313
  18. Natural killer T cells in lipoprotein metabolism and atherosclerosis. Thromb Haemost. 2011 Nov; 106(5):814-9.
    View in: PubMed
    Score: 0.309
  19. 4F Peptide reduces nascent atherosclerosis and induces natural antibody production in apolipoprotein E-null mice. FASEB J. 2011 Jan; 25(1):290-300.
    View in: PubMed
    Score: 0.288
  20. ABC transporters: lipid transport and inflammation. Curr Opin Lipidol. 2010 Apr; 21(2):159-60.
    View in: PubMed
    Score: 0.279
  21. Biological properties of apolipoprotein a-I mimetic peptides. Curr Atheroscler Rep. 2010 Mar; 12(2):96-104.
    View in: PubMed
    Score: 0.277
  22. HDL apolipoprotein-related peptides in the treatment of atherosclerosis and other inflammatory disorders. Curr Pharm Des. 2010; 16(28):3173-84.
    View in: PubMed
    Score: 0.274
  23. Apoprotein A-I mimetic peptides and their potential anti-atherogenic mechanisms of action. Curr Opin Lipidol. 2009 Jun; 20(3):171-5.
    View in: PubMed
    Score: 0.263
  24. VLDL best predicts aortic root atherosclerosis in LDL receptor deficient mice. J Lipid Res. 2009 Mar; 50(3):376-385.
    View in: PubMed
    Score: 0.253
  25. Apolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties. J Lipid Res. 2008 Jun; 49(6):1268-83.
    View in: PubMed
    Score: 0.241
  26. Murine atherosclerosis. Part III. Curr Drug Targets. 2008 Mar; 9(3):173.
    View in: PubMed
    Score: 0.241
  27. The immune system and murine atherosclerosis. Curr Drug Targets. 2007 Dec; 8(12):1297-306.
    View in: PubMed
    Score: 0.237
  28. Overview of murine atherosclerosis series. Curr Drug Targets. 2007 Nov; 8(11):1144-9.
    View in: PubMed
    Score: 0.236
  29. Nutrition and cardiovascular disease. Arterioscler Thromb Vasc Biol. 2007 Dec; 27(12):2499-506.
    View in: PubMed
    Score: 0.235
  30. Arginine/arginase NO NO NO. Arterioscler Thromb Vasc Biol. 2006 Feb; 26(2):237-9.
    View in: PubMed
    Score: 0.209
  31. Diet and murine atherosclerosis. Arterioscler Thromb Vasc Biol. 2006 Feb; 26(2):242-9.
    View in: PubMed
    Score: 0.207
  32. Site-specific influence of polyunsaturated fatty acids on atherosclerosis in immune incompetent LDL receptor deficient mice. Atherosclerosis. 2006 Aug; 187(2):325-31.
    View in: PubMed
    Score: 0.206
  33. Apoprotein E and Reverse Cholesterol Transport. Int J Mol Sci. 2018 Nov 06; 19(11).
    View in: PubMed
    Score: 0.126
  34. Hypercholesterolemia-Induced Loss of Flow-Induced Vasodilation and Lesion Formation in Apolipoprotein E-Deficient Mice Critically Depend on Inwardly Rectifying K+ Channels. J Am Heart Assoc. 2018 03 03; 7(5).
    View in: PubMed
    Score: 0.121
  35. Deficiency of Invariant Natural Killer T Cells Does Not Protect Against Obesity but Exacerbates Atherosclerosis in Ldlr-/- Mice. Int J Mol Sci. 2018 Feb 08; 19(2).
    View in: PubMed
    Score: 0.120
  36. The western-type diet induces anti-HMGB1 autoimmunity in Apoe(-/-) mice. Atherosclerosis. 2016 08; 251:31-38.
    View in: PubMed
    Score: 0.107
  37. Proteomic analysis of HDL from inbred mouse strains implicates APOE associated with HDL in reduced cholesterol efflux capacity via the ABCA1 pathway. J Lipid Res. 2016 Feb; 57(2):246-57.
    View in: PubMed
    Score: 0.103
  38. Serum Amyloid A Facilitates Early Lesion Development in Ldlr-/- Mice. J Am Heart Assoc. 2015 Jul 17; 4(7).
    View in: PubMed
    Score: 0.101
  39. The apolipoprotein-AI mimetic peptide L4F at a modest dose does not attenuate weight gain, inflammation, or atherosclerosis in LDLR-null mice. PLoS One. 2014; 9(10):e109252.
    View in: PubMed
    Score: 0.095
  40. Cutting edge: Dexamethasone potentiates the responses of both regulatory T cells and B-1 cells to antigen immunization in the ApoE(-/-) mouse model of atherosclerosis. J Immunol. 2014 Jul 01; 193(1):35-9.
    View in: PubMed
    Score: 0.093
  41. The structure/function of apoprotein A-I mimetic peptides: an update. Curr Opin Endocrinol Diabetes Obes. 2014 Apr; 21(2):129-33.
    View in: PubMed
    Score: 0.092
  42. Apolipoprotein A-I protection against atherosclerosis is dependent on genetic background. Arterioscler Thromb Vasc Biol. 2014 Feb; 34(2):262-9.
    View in: PubMed
    Score: 0.090
  43. Increased levels of invariant natural killer T lymphocytes worsen metabolic abnormalities and atherosclerosis in obese mice. J Lipid Res. 2013 Oct; 54(10):2831-41.
    View in: PubMed
    Score: 0.088
  44. ApoE derived from adipose tissue does not suppress atherosclerosis or correct hyperlipidemia in apoE knockout mice. J Lipid Res. 2013 Jan; 54(1):202-13.
    View in: PubMed
    Score: 0.083
  45. Vitamin D receptor signaling inhibits atherosclerosis in mice. Mol Endocrinol. 2012 Jul; 26(7):1091-101.
    View in: PubMed
    Score: 0.081
  46. Human oxidation-specific antibodies reduce foam cell formation and atherosclerosis progression. J Am Coll Cardiol. 2011 Oct 11; 58(16):1715-27.
    View in: PubMed
    Score: 0.077
  47. A novel potent synthetic steroidal liver X receptor agonist lowers plasma cholesterol and triglycerides and reduces atherosclerosis in LDLR(-/-) mice. Br J Pharmacol. 2011 Apr; 162(8):1792-804.
    View in: PubMed
    Score: 0.075
  48. Apoprotein E as a lipid transport and signaling protein in the blood, liver, and artery wall. J Lipid Res. 2009 Apr; 50 Suppl:S156-61.
    View in: PubMed
    Score: 0.063
  49. Antiatherosclerotic effects of a novel synthetic tissue-selective steroidal liver X receptor agonist in low-density lipoprotein receptor-deficient mice. J Pharmacol Exp Ther. 2008 Nov; 327(2):332-42.
    View in: PubMed
    Score: 0.062
  50. Differential anti-atherosclerotic effects in the innominate artery and aortic sinus by the liver X receptor agonist T0901317. Atherosclerosis. 2009 Mar; 203(1):59-66.
    View in: PubMed
    Score: 0.062
  51. Serum amyloid A regulates monopoiesis in hyperlipidemic Ldlr(-/-) mice. FEBS Lett. 2016 08; 590(16):2650-60.
    View in: PubMed
    Score: 0.027
  52. Enzymatically Modified Low-Density Lipoprotein Promotes Foam Cell Formation in Smooth Muscle Cells via Macropinocytosis and Enhances Receptor-Mediated Uptake of Oxidized Low-Density Lipoprotein. Arterioscler Thromb Vasc Biol. 2016 06; 36(6):1101-13.
    View in: PubMed
    Score: 0.026
  53. Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice. J Exp Med. 2009 Jan 16; 206(1):233-48.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.